Wayne Hsueh, MD
Otolaryngology · Newark, NJNPI 1407113921
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (49.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Olympus America Inc. at 51.8% of the total. Reporting peaked in 2022 at $4,531 and has fallen 74.5% since, to $1,155 in 2025. Among otolaryngology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 106 payments — averaging $68.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Olympus America Inc.$4K
- Optinose US, Inc.$1K
- Stryker$474
- Intersect ENT, Inc.$428
- Acclarent, Inc$311
- Regeneron Healthcare Solutions, Inc.$255
- plus $992 from 8 others
What the payments were for
- Consulting fees$3,61350%
- Travel & lodging$1152%
- Food & beverage$3,42547%
- Education$871%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Olympus America Inc. | 5 | $3,751 |
| Optinose US, Inc. | 36 | $1,028 |
| Stryker | 9 | $474 |
| Intersect ENT, Inc. | 5 | $428 |
| Acclarent, Inc | 5 | $311 |
| Regeneron Healthcare Solutions, Inc. | 10 | $255 |
| Sanofi | 13 | $236 |
| GSK | 12 | $221 |
| Davol Inc. | 2 | $174 |
| Aerin Medical Inc. | 1 | $138 |
| Amgen | 3 | $68 |
| Integra Lifesciences Corporation | 3 | $61 |
| Sanofi-aventis U.S. LLC | 1 | $53 |
| 3-d Matrix, Inc. | 1 | $41 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MULTIDEBRIDER HANDPIECE, ANGLED DIEGO ELITE$3,613
- Xhance$491
- Navigation CUBE$176
- SCOPIS ENT$151
- SINUVA$138
- DUPIXENT$127
- GAMMA$108
How this compares
$7,239 in reported general payments places this provider in the 95th percentile of 232 otolaryngology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 179 | $5,008 |
| Azelastine Hcl | 149 | $3,390 |
| Fluticasone Propionate | 96 | $1,190 |
| Levocetirizine Dihydrochloride | 130 | $767 |
| Mupirocin | 73 | $453 |
| Montelukast Sodium | 43 | $328 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 35 | $254 |
| Famotidine | 17 | $233 |
| Methylprednisolone | 25 | $210 |
| Prednisone | 67 | $181 |
| Azithromycin | 40 | $158 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 24 | $130 |
| Levofloxacin | 11 | $24 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Newark
- Jean EloyNewark$8K
- Ghayoour MirNewark$5K
- Evelyne KalyoussefNewark$4K
- Roman PovolotskiyNewark$3K
- Nishant ReddyEast Windsor$133K
- Giant LinFlorham Park$25K
- Samir ShahVoorhees$16K
- Brian BensonHackensack$14K
- Andrew BlitzerHackensack$9K
- Ahmad MahmoudClifton$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.